Pharma, Consumer Advocates Clash Over FDA-USPTO Collab
Major pharmaceutical organizations are urging the U.S. Patent and Trademark Office and U.S. Food and Drug Administration not to work closer on drug patents, arguing the current system works well to...To view the full article, register now.
Already a subscriber? Click here to view full article